Dementia  Neuropsychologia is a quarterly journal dedicated to publishing research in cognitive and behavioral sciences, focusing on clinical epidemiology, basic and applied neurosciences, and cognitive tests devised or adapted for populations with heterogeneous cultural, educational and socioeconomic backgrounds. Dementia Neuropsychologia is particularly involved in publishing research relevant to developing countries, and also seeks to disseminate reviews and case reports that are important contributions to neurological, psychiatric, geriatric, neuropsychological, speech therapy, occupational therapy and related fields.
The journal is published in the English language but also includes Portuguese versions of the title, abstract and key words. Manuscripts prepared in Portuguese or Spanish can also be accepted and translated by our native English-speaking board for an additional fee.
Dementia Neuropsychologia follows the guidelines of the ICMJE (International Committee of Medical Journal Editors: Uniform requirements for manuscripts submitted to biomedical journals editors October 2008 update; www.icmje.org).
In concert with the International Committee of Medical Journal Editors (ICMJE), Dementia Neuropsychologia will require, as a condition of consideration for publication, registration of clinical trials in a public trials registry. Acceptable trial registries include http://clinicaltrials.gov, http://isrctn.org, http://actr.org.au, http://trialregister.nl, and http://www.umin.ac.jp/ctr. For this purpose, the ICMJE defines a clinical trial as any study that prospectively assigns human subjects to intervention or comparison groups to evaluate the cause-and-effect relationships between a medical intervention and a health outcome. The trial registry name and URL and the registration number should be included at the end of the abstract. Trials must be registered at or before the onset of patient enrollment.
In agreement with BIREME/PAHO/WHO recommendations for reporting of randomized trials, authors are advised to adhere to the guidelines in the CONSORT STATEMENT (www.consort-statement.org).
EDITORIAL POLICIES FOR AUTHORS
Authorship responsibility, criteria, and contributions; financial disclosure; and copyright transfer. The cover letter includes (1) statement on authorship responsibility, (2) statement on financial disclosure, and (3) copyright transfer agreement. Each of these first 3 statements must be read and signed by all authors. (See the Authorship Form and an example of cover letter).
Conflict of interest. A conflict of interest may exist when an author (or the author's institution or employer) has financial or personal relationships that could inappropriately influence (or bias) the author's decisions, work, or manuscript. All authors are required to report potential conflicts of interest, including specific financial interests relevant to the subject of their manuscript, in their cover letter, on the Dementia Neuropsychologia financial disclosure form, or in an attachment to the form. Authors without relevant financial interests in the manuscript should indicate this lack of interest.
Authors are required to report detailed information regarding all financial and material support for the research and work, including but not limited to grant support, funding sources, and provision of equipment and supplies.
Authors are expected to provide detailed information about any relevant financial interests or financial conflicts within the past 5 years and for the foreseeable future, particularly those present at the time the research was conducted and up to the time of publication. In addition, authors who have no relevant financial interests are asked to provide a statement indicating that they have no financial interests related to the material in the manuscript.
The policy requesting disclosure of conflicts of interest applies for all manuscript submissions, including letters to the editor and book reviews.
Funding/support and role of sponsor. All financial and material support for the research and the work should be clearly and completely identified in an acknowledgment.
Data access and responsibility. For clinical trials sponsored by pharmaceutical companies, authors must state in their letter of submission that (1) they have had full access to all the data, (2) they have the right to publish all the data, and (3) they have had the right to obtain independent statistical analyses of the data. Manuscripts containing statistical evaluations should include the name and affiliation of the statistical reviewer.
Duplicate previous publication or submission. Manuscripts are received with the understanding that they are not under simultaneous consideration by another publication. This information must be inserted in the cover letter.
Informed consent. For experimental investigations of human or animal subjects, state in the "Methods" section of the manuscript that an appropriate institutional review board has approved the project. For those investigators who do not have formal ethics review committees (institutional or regional), the principles outlined in the Declaration of Helsinki should be followed. For investigations of human subjects, state in the "Methods" section the manner in which informed consent was obtained from the subjects. A letter of consent must accompany all photographs of patients in which a possibility of identification exists. It is not sufficient to cover the eyes to mask identity. Refer to patients by number (or in anecdotal reports, by assigning fictitious names). Real names or initials should not be used in the text, tables, or illustrations.
Unauthorized use. Accepted manuscripts become the permanent property of Dementia Neuropsychologia and may not be published elsewhere without permission from the publisher.
EDITORIAL REVIEW AND PUBLICATION
Procedures to submit manuscripts cover the following steps:
Manuscripts must be submitted on line, with cover-letter and Authorship Responsibility, Financial Disclosure, Acknowledgement, and Copyright Transfer/Publishing Agreement (see models below).
Studies that include human beings should be submitted together with a copy of the Ethics Committee authorization from the appropriate institution involved.
Clinical studies will be accepted for publication, pending the presentation of Clinical Trial Registers.
1. All submitted manuscripts are reviewed initially by an editor. Manuscripts with insufficient priority for publication are rejected promptly.
2. Initial screening will be performed by a junior editors to verify the formal eligibility of the manuscript according to the editorial norms of Dementia Neuropsychologia.
3. Manuscripts are sent for peer-review (see below).
4. The authors are informed of the probable date of publication following the final decision of the Editor-in-Chief.
The authors may be asked for additional information regarding previous presentation in Scientific Meetings. This information can be supplied in the cover-letter sent at the time of manuscript submission.
Peer review
1. After approval of formal aspects, the manuscript is submitted to peer-review by ad-hoc consultants, international and national specialists. Each manuscript is evaluated by at least two reviewers. Peer reviewer identities are kept confidential, and authors' identities are also not divulged to reviewers.
2. The referees' comments and suggestions are sent to the authors of the manuscript within 60 days for reworking of the paper.
3. The reformulated version is accepted as a re-submission and re-sent to the referees for further review.
4. In the case of referee approval, the manuscript is revised by the editor and associate editors and passes to the publishing step.
5. In the case of pending issues the manuscript is again returned to the authors with indications for revision.
6. The entire process is supervised by the Editor-in-Chief who determines the number of appropriate re-submissions, while focusing on the quality of the work being published. .
MANUSCRIPT PREPARATION
Information for authors is available on line (demneuropsy.com.br; and also at abneuro.org). Please follow these instructions:
Cover letter. Designates the corresponding author, authorship responsibility, contributions, financial support, and conflict of interests and provides full address, telephone, and fax numbers, and e-mail address.
Title page. Includes manuscript title and authors' names. The title should be concise and descriptive, with essential information on the manuscript content. The name of the authors should include the first name. At the bottom of the title page indicate: the name of the department and institution, city and country in which the study was conducted; the academic title of each author and their institutional affiliation; grant support acknowledgement; name and address (postal and electronic) for mail.
Abstract. The abstract of original manuscripts or short communications should be structured and contain the following items: background, objective(s), methods, results and conclusions. Abstracts may contain up to 250 words. Abstracts of case reports or reviews may be unstructured and contain up to 150 words.
Key words. Add key words (three to four) or short phrases after the abstract, following the Descriptors for Health Sciences (http://decs.bvs.br/).
- Title, abstract and key words must also be provided in a Portuguese version (for those who do not write in Portuguese, the editorial office will translate these items).
Text. Original manuscripts should have up to 3,000 words and contain: introduction and objectives; methods (material and/or subjects; statistical methods; bioethical approach with the name of the Ethics Committee that approved the study and patient Informed Consent); results; discussion (which should include the conclusions); acknowledgements. Data presented in tables and illustrations should not be repeated in the text. Observations: Short communication and case report: up to 1,500 words of text; reviews up to 5,000 words.
References. Up to 50 for original manuscripts, numbered consecutively in the order they are cited. For case reports or short communications up to 30, and reviews up to 100 references. The references should follow the standard Index Medicus. List all authors when there are six or less; when there are seven or more, list the first three then follow with "et al."
- Articles: Author(s).Title. Journal year;volume:pages initial-final.
- Books: Author(s) or editor(s). Title. Edition- if not the first. City where published: publisher; year:number of pages.
- Chapter of a book: Author(s). Title. In: Book editor(s) followed by (eds), Title, Edition- if not the first. City where published: publisher; year:pages initial-final.
- Abstracts: Author(s).Title, followed by (Abstr). Journal year; volume (Supplement and number if necessary):page(s) or, in case of abstracts not published in journals: Title of the publication. City where published: publisher, year:page(s).
Tables. Up to 5 tables in original manuscripts (up to 2 tables in short communications or case reports), each presented on a separate page together with its title, legend and sequence number. Tables should contain all information required to be understood by the reader. Vertical lines should not be used for separating data within the table. Type or print out each table double spaced on a separate page. Do not submit tables as photographs. Number tables consecutively in the order of their first citation in the text and supply a brief title for each. Give each column a short or abbreviated heading. Place explanatory matter in footnotes, not in the heading. Explain in footnotes all non-standard abbreviations used in each table. For footnotes use the following symbols, in this sequence: *, +, +, §, ||, ¶, **, ++, ++, etc. The editor, on accepting a manuscript, may recommend that additional tables containing important supporting data too extensive to publish be deposited with an archival service, such as the site of the journal (www.demneuropsy.com.br), or be made available by the authors. In this case an appropriate statement will be added to the text. Submit all tables for consideration together with the manuscript.
Illustrations. Up to 3 figures, graphs or photos, with their title and legend on separate pages (up to 2 illustrations in short communications or case reports).
Attention. Before sending the manuscript to demneuropsy@uol.com.br, please go through the Author's checklist and complete the Authorship, non-financial, and financial disclosure forms available online from the journal's homepage (www.demneuropsy.com.br) or from the Brazilian Academy of Neurology homepage (www. abneuro.org).
|
|
|
 |
 |
